Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 87/100 Charles River Laboratories International Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 13, 2021 / 02:15PM GMT
Release Date Price:
$431.22
(-2.22%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Hey, everyone. Good morning. Thanks for joining us at the Morgan Stanley Healthcare Conference. I'm Tejas Savant, and I cover the life science tools and diagnostics sector here at Morgan Stanley. I'm delighted to have Charles River join us this morning. And representing the company is Jim Foster, Chairman, President and CEO. So welcome, Jim.
James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President
Nice to be here.
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
Before we get into the Q&A, I just wanted to quickly rattle off my safe harbor. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please do reach out to your sales rep.
Questions & Answers
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst
So with that, thanks for
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot